Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
BenevolentAI is a pioneering platform that leverages artificial intelligence and scientific technology to enhance drug discovery processes, specifically targeting complex diseases by efficiently processing and interpreting extensive biomedical data to yield actionable insights more swiftly than conventional approaches. By utilizing its unique Benevolent Platform, the company seamlessly integrates both structured and unstructured biomedical information—spanning literature, genomics, clinical data, and multi-omics—into a detailed knowledge graph. This robust framework empowers researchers to analyze biological systems, formulate testable hypotheses, identify new drug targets, and create potential drug candidates with increased confidence and reduced failure rates, ultimately transforming the landscape of medicine development. With its innovative approach, BenevolentAI stands at the forefront of a new era in the pharmaceutical industry.
Description
Nygen serves as a cloud-driven platform for the analysis and discovery of single-cell RNA sequencing (scRNA-seq) and multi-omics data, allowing researchers to seamlessly upload, explore, visualize, analyze, and interpret intricate cellular datasets through an easy-to-use, no-code interface that promotes drag-and-drop workflows and sophisticated scientific analysis without the need for programming knowledge. This platform merges Nygen Analytics for swift and reproducible exploration of scRNA-seq data with collaborative dashboards that produce publication-ready outputs, integrates Nygen Database for easy access to curated single-cell datasets to enhance research and comparative studies, and includes Nygen Insights, an AI-enhanced feature that offers precise cell annotations, thorough disease impact assessments, and customized biological insights. Furthermore, it accommodates a variety of data formats, integrates public datasets, fosters secure cloud collaboration, and offers functionalities such as literature-linked evidence and analyses focused on biomarkers, ultimately empowering researchers to derive meaningful conclusions from their data. By streamlining complex analytical processes, Nygen significantly enhances the efficiency of scientific research and discovery.
API Access
Has API
No
API Access
Has API
No
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
Yes
In Person
No
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
Yes
In Person
No
Vendor Details
Company Name
BenevolentAI
Founded
2013
Country
Luxembourg
Website
www.benevolent.com
Vendor Details
Company Name
Nygen
Founded
2022
Country
Sweeden
Website
www.nygen.io